Medicare coverage of the drugs would up federal spending by $35 billion from 2026 to 2034. Meanwhile, CNBC tests Abbott's continuous glucose monitor Lingo.

Providing coverage for weight-loss drugs such as Wegovy and Ozempic is forcing employers to make some critical decisions.

In response to the rapid increase in the number of adults taking a weight loss drug - an estimated 18 million adults - health ...

This research contradicts previous concerns about the potential of drugs like Ozempic to trigger suicidal ideation and ...

The Government is considering using drugs to help get obese people back to work - but they can lead to serious health ...

Health Secretary Wes Streeting is planning to offer jobless Brits free jabs of the drugs like Wegovy, a cousin of Ozempic, ...

Hoping your company will begin paying for anti-obesity medications like Wegovy? You may be in luck. A growing number of ...

India’s powerful copycat pharmaceutical industry is set to roll out generic weight loss drugs in the U.K. within weeks ...

A surge in the use of GLP-1 drugs is among the reasons a new report projects a calorie intake decline of 10 quadrillion in U.S. adults by 2030.

In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and ...

Drugs like Ozempic and Wegovy may provide a surprising, life-saving benefit for the youngest patients taking these diabetes and weight loss medications.